HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard T Clements Selected Research

ameroid

1/2022Calpain inhibition decreases myocardial fibrosis in chronically ischemic hypercholesterolemic swine.
12/2016Glycogen Synthase Kinase 3β Inhibition Improves Myocardial Angiogenesis and Perfusion in a Swine Model of Metabolic Syndrome.
8/2011Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia.
10/2010Temporal and spatial changes in collateral formation and function during chronic myocardial ischemia.
9/2010Effects of diabetes mellitus on VEGF-induced proliferation response in bone marrow derived endothelial progenitor cells.
8/2010Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome.
7/2008Atorvastatin increases myocardial indices of oxidative stress in a porcine model of hypercholesterolemia and chronic ischemia.
3/2008Coronary microvascular dysfunction in the setting of chronic ischemia is independent of arginase activity.
1/2008Atorvastatin impairs the myocardial angiogenic response to chronic ischemia in normocholesterolemic swine.
12/2007Insulin treatment enhances the myocardial angiogenic response in diabetes.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard T Clements Research Topics

Disease

18Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 12/2007
13Ischemia
01/2022 - 09/2007
7Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018 - 08/2010
7Reperfusion Injury
01/2017 - 12/2007
5Hypercholesterolemia
01/2022 - 07/2008
5Coronary Artery Disease (Coronary Atherosclerosis)
01/2022 - 02/2009
4Fibrosis (Cirrhosis)
01/2022 - 01/2017
4Infarction (Infarctions)
07/2010 - 05/2008
3Pulmonary Hypertension
01/2021 - 11/2019
3Hypertrophy
11/2019 - 01/2017
3B-Cell Lymphoma (Lymphoma, B Cell)
04/2010 - 03/2009
3Necrosis
10/2009 - 05/2008
2Heart Diseases (Heart Disease)
01/2021 - 01/2020
2Cardiomegaly (Heart Hypertrophy)
01/2020 - 01/2017
2Cardiovascular Diseases (Cardiovascular Disease)
07/2013 - 08/2011
2Coronary Disease (Coronary Heart Disease)
01/2008 - 12/2007
1Ventricular Tachycardia
10/2021
1Heart Failure
10/2021
1Diabetic Cardiomyopathies
10/2021
1Pulmonary Arterial Hypertension
04/2020
1Hypoxia (Hypoxemia)
11/2019
1Vascular Remodeling
11/2019
1Leukemia
01/2018
1Alcoholic Liver Diseases (Alcoholic Liver Disease)
01/2016
1Obesity
08/2011
1Metabolic Diseases (Metabolic Disease)
08/2011
1Chronic Disease (Chronic Diseases)
09/2010
1Diabetes Mellitus
09/2010
1Inflammation (Inflammations)
10/2009
1Myocardial Reperfusion Injury
03/2009
1Myocardial Infarction
03/2009
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2009
1Type 2 Diabetes Mellitus (MODY)
05/2008
1Acidosis
01/2008

Drug/Important Bio-Agent (IBA)

11ameroidIBA
01/2022 - 09/2007
10Proteins (Proteins, Gene)FDA Link
04/2020 - 02/2005
5CollagenIBA
01/2022 - 01/2017
5ResveratrolIBA
01/2016 - 08/2010
4Insulin (Novolin)FDA Link
01/2017 - 12/2007
4ChloridesIBA
07/2010 - 06/2009
3CalpainIBA
01/2022 - 01/2017
3Glycogen Synthase KinasesIBA
01/2018 - 12/2016
3Hydrogen Sulfide (Sulfide, Hydrogen)IBA
10/2009 - 05/2008
2CholesterolIBA
01/2022 - 06/2009
2Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
10/2021 - 01/2021
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2021 - 01/2017
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018 - 02/2005
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2011 - 09/2010
2Sulfides (Thioethers)IBA
10/2009 - 05/2008
2HSP27 Heat-Shock ProteinsIBA
10/2009 - 12/2007
2Evans Blue (Blue, Evans)FDA Link
10/2009 - 05/2008
2Crystallins (Crystallin)IBA
10/2009 - 12/2007
2ThrombinFDA Link
06/2009 - 03/2009
2rusalatide acetate (Chrysalin)IBA
06/2009 - 03/2009
2Atorvastatin (Lipitor)FDA Link
07/2008 - 01/2008
1CalciumIBA
10/2021
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
01/2020
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2020
1Angiotensin IIIBA
11/2019
1Natriuretic PeptidesIBA
11/2019
1Semaxinib (SU5416)IBA
11/2019
1Angiotensin Receptor AntagonistsIBA
11/2019
1sacubitril and valsartan sodium hydrate drug combinationIBA
11/2019
1Neprilysin (Neutral Endopeptidase)IBA
11/2019
1kaempferolIBA
01/2018
1Caspase 3 (Caspase-3)IBA
01/2018
1Apoptosis Regulatory ProteinsIBA
01/2018
1CGP 37157IBA
01/2018
1Ru 360IBA
01/2018
1Matrix Metalloproteinase 9 (Gelatinase B)IBA
01/2018
1CateninsIBA
01/2017
1SmokeIBA
01/2017
1calpain inhibitorsIBA
01/2017
1NicotineFDA Link
01/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017
1Glucose (Dextrose)FDA LinkGeneric
01/2016
1NADPH Oxidases (NAD(P)H oxidase)IBA
07/2013
1AntioxidantsIBA
07/2013
1erucylphosphocholineIBA
09/2010
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
04/2010
1Proto-Oncogene Proteins c-bcl-2 (Proto Oncogene Proteins c bcl 2)IBA
09/2009
1Mechanistic Target of Rapamycin Complex 1IBA
06/2009
1Mechanistic Target of Rapamycin Complex 2IBA
06/2009
1Poly Adenosine Diphosphate RiboseIBA
03/2009
1AngiostatinsIBA
02/2009
1EndostatinsIBA
02/2009
1AlloxanIBA
02/2009
1ArginaseIBA
03/2008
1Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2008
1Arginine (L-Arginine)FDA Link
03/2008
1Ion Channels (Ion Channel)IBA
01/2008
1Oxidoreductases (Dehydrogenase)IBA
01/2008
1Coenzyme A (CoA)IBA
01/2008
1Phosphotransferases (Kinase)IBA
01/2008
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2008

Therapy/Procedure

6Therapeutics
01/2022 - 10/2007
1Diet Therapy (Therapy, Diet)
08/2011
1General Anesthesia
10/2010
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
05/2008
1Induced Heart Arrest (Cardioplegia)
01/2008